Author:
Arora Geetanjali,Bandopadhyaya Gurupad
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,General Medicine
Reference84 articles.
1. Oberg KE. Management of neuroendocrine tumors: current and future therapies. Exp Rev Endocrinol Metab. 2011;6:49–62.
2. Boudreaux JP, Klimstra DS, Hassan MM, Woltering EA, Jensen RT, Goldsmith SJ, et al. The NANET consensus guideline for the diagnosis and management of neuroendocrine tumors (well-differentiated neuroendocrine tumors of the jejunum, ileum, appendix, and cecum). Pancreas. 2010;39:753–66.
3. Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas. 2010;39:707–12.
4. Patel YC. Somatostatin and its receptor family. Front Neuroendocrin. 1999;20:157–98.
5. Bal CS, Gupta SK, Zaknun JJ. Radiolabeled somatostatin analogs for radionuclide imaging and therapy in patients with gastroenteropancreatic neuroendocrine tumors. Trop Gastroenterol. 2010;31:87–95.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献